CapsoVision (CV) announced submission of its 510(k) application to the FDA for its proprietary AI-assisted module for CapsoCam Plus. The company intends for U.S. commercialization activities to commence after the FDA clearance.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CV: